Main Menu
About
Overview
Amgen History
Mission and Values
Leadership
Awards and Accolades
How We Operate
Overview
Corporate Governance
Business Ethics and Compliance
Policies, Practices and Disclosures
Science
Overview
Research and Development Strategy
Pipeline
Scientific Advisory Boards
Amgen Science
Amgen Competitive Grants
Biosimilars
Clinical Trials
Overview
About Clinical Trails
Amgen Clinical Trails
Clinical Trial Diversity
Information for Healthcare Professionals
Clinical Trial Transparency, Data Sharing and Disclosure Practices
Clinical Out-of-Hours Support program
Investigator Sponsored Studies
Scientific Community Initiatives
Overview
Educational Outreach Program
Postdoctoral Fellows Program
Scientific Conferences Program
Start-Up Network Program
Manufacturing
Overview
Innovation
Quality
Reliability
PRODUCTS
Overview
Medical Information
Counterfeit Drug Statement
Safety Data Sheets
Global Patient Safety
Overview
Who We Are
Our Commitment
What We Do
Adverse Event and Product Complaint Reporting
Responsibility
Overview
2019 Responsibility Highlights Report
Corporate Responsibility
Strategy & Governance
Overview
Amgen’s Commitment to Patients
Our Approach to Pricing,
Access and Affordability
Access Approaches, Treatments, and Collaborations
Transformative Treatments, Approaches, and Technology
Shaping the Future of Healthcare
Access to Medicine
U.S. Reimbursement Support Services and Financial Assistance Programs
Access to Medicines Initiatives Outside the U.S.
Access to Investigational Medicines
Amgen Foundation
Overview
About the Amgen Foundation
Amgen Foundation Grants
Programs for Teachers
Programs for Students
About the Amgen Foundation
Commitment to Community
Overview
Staff Engagement Programs
Independent Medical Education Funding
U.S. Healthcare Donations
Non-Healthcare Donations and Sponsorships
Equipment Donations
Donation and Grant Recipients
Diversity, Inclusion and Belonging
Amgen's Commitment to Diversity, Inclusion and Belonging
Environment
Overview
Performance
2027 Plan
Sustainable by Design
Case Studies
Responsible Sourcing
Supplier Diversity
Supplier Sustainability
Workplace
Safety
Wellness
Reporting and Metrics
Overview
Archived Reports
Summary of Data
CDP
Stakeholder Engagement
Stories
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Popular Tags
COVID-19
Supporting Our Staff
Leveraging Our Science
Serving Our Communities
Newsroom
Partners
Investors
Careers
Amgen Worldwide
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Popular Tags
COVID-19
Supporting Our Staff
Leveraging Our Science
Serving Our Communities
About
Overview
Amgen History
Mission and Values
Leadership
Awards and Accolades
How We Operate
Corporate Governance
Business Ethics and Compliance
Policies, Practices and Disclosures
Science
Overview
Research and Development Strategy
Pipeline
Scientific Advisory Boards
Amgen Science
Amgen Competitive Grants
Biosimilars
Clinical Trials
About Clinical Trials
Amgen Clinical Trials
Clinical Trial Diversity
Information for Healthcare Professionals
Clinical Trial Transparency, Data Sharing and Disclosure Practices
Clinical Out-of-Hours Support Program
Investigator Sponsored Studies
Scientific Community Initiatives
Educational Outreach Program
Postdoctoral Fellows Program
Scientific Conferences Program
Start-Up Network Program
Manufacturing
Innovation
Quality
Reliability
PRODUCTS
Overview
Medical Information
Counterfeit Drug Statement
Safety Data Sheets
Global Patient Safety
Who We Are
Our Commitment
What We Do
Adverse Event and Product Complaint Reporting
Responsibility
Overview
2019 Responsibility Highlights Report
Corporate Responsibility Strategy & Governance
Amgen's Commitment to Patients
Our Approach to Pricing, Access and Affordability
Access Approaches, Treatments, and Collaborations
Transformative Treatments, Approaches and Technology
Shaping the Future of Healthcare
Access to Medicine
U.S. Reimbursement Support Services and Financial Assistance Programs
Access to Medicines Initiatives Outside the U.S.
Access to Investigational Medicines
Amgen Foundation
Amgen Inspires
About the Amgen Foundation
Programs for Teachers
Programs for Students
Amgen Foundation Grants
Commitment to Community
Staff Engagement Programs
Independent Medical Education Funding
U.S. Healthcare Donations
Non-Healthcare Donations and Sponsorships
Equipment Donations
Donation and Grant Recipients List
Diversity, Inclusion & Belonging
Amgen's Commitment to Diversity, Inclusion and Belonging
Environment
Performance
2027 Plan
Sustainable by Design
Case Studies
Responsible Sourcing
Supplier Diversity
Supplier Sustainability
Workplace
Safety
Wellness
Reporting and Metrics
Summary of Data
CDP
Stakeholder Engagement
Archived Reports
Stories
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Popular Tags
COVID-19
Supporting Our Staff
Leveraging Our Science
Serving Our Communities
Newsroom
Partners
Investors
Careers
X
Home
>
Stories
>
All Stories
RESPONSIBILITY
11.24.2020
How Some Black Women Experience Cancer, COVID and the Healthcare System
A Q&A with Maimah Karmo, CEO of the Tigerlily Foundation, and global advocate for young Black women with breast cancer.
Read more
All Stories
All
PATIENTS
RESPONSIBILITY
LEADERSHIP
SCIENCE & INNOVATION
PEOPLE & CULTURE
All
PATIENTS
RESPONSIBILITY
LEADERSHIP
SCIENCE & INNOVATION
PEOPLE & CULTURE
PATIENTS
01.22.2021
Survey Uncovers Disconnect Related to Perception of Psoriasis Severity
RESPONSIBILITY
01.13.2021
Discussing COVID-19, Chronic Disease and the New U.S. Administration on Bloomberg TV
SCIENCE & INNOVATION
01.12.2021
Amgen to Showcase New Data From Its Oncology Pipeline in Lung Cancer at the World Conference on Lung Cancer
SCIENCE & INNOVATION
01.07.2021
Amgen Paper Selected for Best of
Cell
, a Rare Honor for Industry Scientists
SCIENCE & INNOVATION
01.05.2021
5 Things to Watch in the U.S. Biosimilars Landscape in 2021
SCIENCE & INNOVATION
12.21.2020
Polygenic Scores Poised to Play Big Role in Disease Prediction and Prevention
LEADERSHIP
12.17.2020
Amgen CEO: Greater U.S.-China Collaboration Will Accelerate Fight Against Cancer
LEADERSHIP
12.16.2020
Amgen Ranks 26th on Wall Street Journal’s List of Best-Managed Companies
SCIENCE & INNOVATION
12.16.2020
Decoding 5 Recent Regulatory and Development Steps for Sotorasib
PATIENTS
12.14.2020
Karamo Brown on Speaking Up About Migraine
LEADERSHIP
12.14.2020
Amgen CEO Bob Bradway Highlights Advances Against COVID-19 and Other Diseases at Major Healthcare Conferences
RESPONSIBILITY
12.10.2020
Amgen Joins Coalition to Hire One Million Black Americans Over 10 Years
SCIENCE & INNOVATION
12.07.2020
Rapidly Advancing Development of Amgen’s Investigational KRAS
G12C
Inhibitor
PATIENTS
12.07.2020
Rapid Innovation in Lung Cancer, From a Patient’s Perspective
SCIENCE & INNOVATION
12.04.2020
BiTE
®
Technology 101: Learn the What, How, Who and Why of Amgen’s Innovative BiTE Immuno-Oncology Platform
RESPONSIBILITY
12.03.2020
Amgen Foundation Announces Recipients of $5.25M to Support Social Justice and Equal Opportunity
PATIENTS
12.02.2020
5 Things You Might Not Know About Crohn’s Disease and Colitis
RESPONSIBILITY
11.24.2020
How Some Black Women Experience Cancer, COVID and the Healthcare System
LEADERSHIP
11.20.2020
Amgen's Clean Sweep in the 2021 All-America Executive Team Rankings
PEOPLE & CULTURE
11.19.2020
In Asia, COVID-19 Sparked a Transformation for Medical Affairs
Load more
Loading...